Vivus (VVUS) Tells Shareholders Its Open to Dissident Settlement - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
First Manhattan Updates on Shareholder Support for Director Change at Vivus (VVUS)
July 11, 2013 6:34 AM EDTFirst Manhattan Co., the owner of approximately 9.9% of the outstanding shares of VIVUS, Inc. (Vivus) (Nasdaq: VVUS), issued an open letter to Vivus' shareholders.
The full text of the letter follows:
July 11, 2013
Dear Fellow Vivus Shareholders:
We are pleased to report that our discussions with Vivus shareholders over these past several months have been very encouraging. We have received support from large and small shareholders alike. Shareholders have thanked us for our efforts to effect much needed change at Vivus. We share your sense... More
First Manhattan Gets More Support for Vivus (VVUS) Director Slate
July 11, 2013 6:30 AM EDTVivus, Inc. (Nasdaq: VVUS) shareholder QVT, its third-largest holder, is said to be backing the nine-director dissident slate for the company. The firm thinks that change needs to happen with the direction of the company, Bloomberg reports Thursday.
... More
VIVUS, Inc. (VVUS) Notes Positive Analyst Commentary Into Annual Meeting
July 10, 2013 7:47 AM EDTVIVUS, Inc. (Nasdaq: VVUS) issued the following statement in connection with the Company's 2013 Annual Meeting of Stockholders, which will be held on July 15, 2013:
VIVUS's July 15, 2013 Annual Meeting of Stockholders is fast approaching and it is extremely important that stockholders know the facts before they vote.
Despite First Manhattan Co's ("FMC") disruptive efforts, the VIVUS Board and management team are making meaningful progress toward unlocking the full potential of Qsymia (phentermine and topiramate extended-release) capsules CIV and STENDRA (avanafil) (SPEDRA in the European Union) and maximizing value for stockholders. Under the... More
